APA

Azijli K., van Roosmalen I. A. M., Smit J., Pillai S., Fukushima M., de Jong S., Peters G. J., Bijnsdorp I. V. & Kruyt F. A. E. (20140918). The novel thymidylate synthase inhibitor trifluorothymidine (TFT) and TRAIL synergistically eradicate non-small cell lung cancer cells. : Cancer chemotherapy and pharmacology.

Chicago

Azijli Kaamar, van Roosmalen Ingrid A M, Smit Jorn, Pillai Saravanan, Fukushima Masakazu, de Jong Steven, Peters Godefridus J, Bijnsdorp Irene V and Kruyt Frank A E. 20140918. The novel thymidylate synthase inhibitor trifluorothymidine (TFT) and TRAIL synergistically eradicate non-small cell lung cancer cells. : Cancer chemotherapy and pharmacology.

Harvard

Azijli K., van Roosmalen I. A. M., Smit J., Pillai S., Fukushima M., de Jong S., Peters G. J., Bijnsdorp I. V. and Kruyt F. A. E. (20140918). The novel thymidylate synthase inhibitor trifluorothymidine (TFT) and TRAIL synergistically eradicate non-small cell lung cancer cells. : Cancer chemotherapy and pharmacology.

MLA

Azijli Kaamar, van Roosmalen Ingrid A M, Smit Jorn, Pillai Saravanan, Fukushima Masakazu, de Jong Steven, Peters Godefridus J, Bijnsdorp Irene V and Kruyt Frank A E. The novel thymidylate synthase inhibitor trifluorothymidine (TFT) and TRAIL synergistically eradicate non-small cell lung cancer cells. : Cancer chemotherapy and pharmacology. 20140918.